1 Min Read
April 3 (Reuters) - Heron Therapeutics Inc:
* In connection with Brian Drazba's departure, CEO Barry Quart assumed role of principal financial officer, effective April 1, 2017 Source text - bit.ly/2n4wPjS Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.